Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
3 Top Biotech Stocks To Watch In May 2022
02:30pm, Monday, 02'nd May 2022
Which biotech stocks do you have on your May 2022 watchlist?
Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates
12:47pm, Monday, 02'nd May 2022
Novo Nordisk (NVO) reports better-than-expected results for Q1. Sales are aided by growth in Diabetes and Obesity Care on higher GLP-1 revenues.
The Zacks Analyst Blog Highlights Novo Nordisk, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and Biogen
10:22am, Monday, 02'nd May 2022 Zacks Investment Research
Novo Nordisk, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and Biogen have been included in this Analyst Blog.
Novo Nordisk: Overvalued Pharma That Should Be Rotated Here
10:28pm, Friday, 29'th Apr 2022
I'll review Novo Nordisk after a chat with one of my fellow contributors on the subject. The company is a popular holding due to its very liquid NYSE-listing NVO. I'll go through what makes the compa
Novo Nordisk (NVO) Q1 2022 Earnings Call Transcript
04:30pm, Friday, 29'th Apr 2022 The Motley Fool
NVO earnings call for the period ending March 31, 2022.
5 Big Pharma, Biotech Stocks Set to Beat Q1 Earnings Estimates
09:11am, Friday, 29'th Apr 2022
Let us take a look at some pharma/biotech stocks, REGN, BIIB, NVO, VRTX and MRNA that are poised to beat on first-quarter earnings.
Novo Nordisk lifts 2022 outlook after strong quarter, shares jump
03:27am, Friday, 29'th Apr 2022
Shares in Novo Nordisk jumped on Friday after the firm lifted its sales and operating profit guidance for the year on the back of forecast-beating first-quarter earnings, driven by strong sales of its
Novo Completes First Tranche of New Found Gold Sale for C$68.9 Million
10:00pm, Wednesday, 27'th Apr 2022 GlobeNewswire Inc.
VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Novo Resources Corp. (“Novo” or the “Company”) (TSX: NVO, NVO.WT & NVO.WT.A) (OTCQX: NSRPF) is pleased to advise that it has c
Novo Nordisk: Inflation Hedge With Upside Potential
06:26pm, Wednesday, 27'th Apr 2022
Novo Nordisk continues to hold its leading position in insulin and the anti-obesity drugs market space that are projected to grow steadily within the next several decades. It has all metrics to inflat
The Zacks Analyst Blog Highlights Novo Nordisk, Advanced Micro Devices, Netflix, Merck, and Marsh & McLennan
10:39am, Wednesday, 27'th Apr 2022 Zacks Investment Research
Novo Nordisk, Advanced Micro Devices, Netflix, Merck, and Marsh & McLennan have been included in this Analyst Blog.
Top Research Reports for Novo Nordisk, AMD & Netflix
09:20pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Advanced Micro Devices, Inc. (AMD), and Netflix, Inc. (NFLX).
Sumitomo Converts Egina Interest to 1.36% Interest in Novo
12:16pm, Thursday, 21'st Apr 2022 GlobeNewswire Inc.
KEY POINTS
Novo Nordisk: Firing On All Cylinders, Which Is Reflected By The Share Price
08:15am, Wednesday, 20'th Apr 2022
Novo Nordisk reported strong growth in fiscal 2021 with revenue and earnings per share growing in the double digits. And due to anti-obesity medications and GLP-1 products, we can expect Novo Nordisk
Novo Nordisk: Growing Obesity Epidemic Will Generate Strong Demand
01:16pm, Monday, 18'th Apr 2022
Sales of obesity therapies grew strongly first 3 quarters of 2021. Obesity and related diseases are increasing in both number of cases and geographic diversity.
2 Unstoppable Green Flags for AbbVie
11:00am, Thursday, 14'th Apr 2022 The Motley Fool
There's a silver lining around an approaching dark cloud.
